Current Regulatory requirements for registration of nutraceuticals in ASEAN

  • Pooja Chaudhari ROFEL Shri G.M Bilakhia College of Pharmacy
  • Jitendra Kumar Badjatya


Nutraceuticals are bioactive or natural chemical components that are been marketed all over the world. It claims to be disease preventing along with health promoting product with some of the medicinal properties. It is categorized as vitamin, mineral, animal product and health supplement. Nutraceuticals has the major advantage over the medicines as they avoid the adverse effects that are caused by drugs. Nutraceutical market is expanding day by day and the claim for the product is enlarging. Users are looking for alternatives for the prescribed medicines as well as the health product that will supplement dietary intake on daily basis. Different countries classified products into various categories depending upon their health claim. In Association of South East Asian Nations (ASEAN) the Asian Alliance of Health Supplement Association (AAHSA) regulates the responsibilities to ensure that the nutraceuticals before marketing are safe.

Keywords: ASEAN, Asian Alliance of Health Supplement Association (AAHSA), nutraceuticals, health supplements


Download data is not yet available.


1. Das L, Bhaumik E, Raychauduri U, Chakraborty R. Role of Nutraceutials in Human Health. Journal of Food Science and Technology [Internet]. 2012 Apr [cited 2021 Nov 14]; 49(2):173-183. Available from:
2. Chauhan B, Kumar G, Kalam N, Ansari SH. Current concepts and prospects of herbal nutraceuticals: A Review. Journal of Advanced Pharmaceutical Technology and Research [Internet]. 2013 Jan [cited 2021 Nov 14]; 4(1):4-8. Available from:
3. Nasri H, Baradaran A, Shirzad h, Rafieian-Kopaei M. New concepts in nutraceuticals as alternative for pharmaceuticals. International Journal of Preventive Medicine [Internet]. 2014 Dec [cited 2021 Nov 14]; 12:1487-1499. Available from:
4. Singh M C, Gujar K N. Nutraceuticals: Uses, Risk and Regulatory Scenario. International Journal of Pharmacy and Pharmaceutical Sciences [Internet]. 2013 Jan [cited 2021 Nov 15]; 5:23-26. Available from:
5. Alicia AG Ng, MJ. ASEAN harmonization of technical standards on health supplements- An industry perspective. Regulatory Focus [Internet]. 2021 Jun [cited 2021 Nov 14]; 1-15. Available from:
6. Wai Mun Poon. ASEAN harmonized standards and requirements for health supplements [Internet]. 2021 Jan [cited 2021 Nov 14]; 1-5. Available from:
7. Health supplements and nutraceuticals compliance guidance. International Alliance of Dietary/Food Supplement Association [Internet]. 2018 Jan [cited 2021 Nov 14]; 1.0:1-60. Available from:
8. Athalya M, Vaghela S, Bhavsar N. Study of the Registration Guideline of Nutraceutical Product in ASEAN countries. Applied Clinical Research, Clinical Trials and Regulatory Affairs [Internet]. 2020 [cited 2021 Nov 14]; 7:1-13. Available from:
9. The ASEAN Common Technical Dossier (ACTD) for the Registration of Pharmaceuticals for Human Use. Organization of the Dossier [Internet]. 2007 [cited 2021 Nov 15]; 1-3. Available from:,of%20pharmaceuticals%20for%20human%20use.
10. ASEAN Common Technical Dossier (ACTD). The ASEAN Secretariat Jakarta [Internet]. 2016 [cited 2021 Nov 16]; 1-198. Available from:
11. ACTD Dossier. Pharma ACTD Dossiers Professionals [Internet]. [cited 2021 Nov 16]. Available from:
12. ANNEX IX ASEAN Guidelines on Labeling Requirements for Health Supplements [Internet]. 2015 Oct [cited 2021 Nov 15]; 1.0;1-14. Available from:
13. Tripathi C, Girme A, Champaneri S, Patel R, Hingorani L. Nutraceutical Regulations: An opportunity in ASEAN countries. Nutrition [Internet]. 2020 Jan [cited 2021 Nov 15]; 74(1):1-15. Available from:
14. Dwyer J, Coates P, Smith M. Dietary Supplements: Regulatory Challenges and Research Resources. Nutrients [Internet]. 2018 Jan [cited 2021 Nov 15]; 10(1);1-24. Available from:
388 Views | 555 Downloads
How to Cite
Pooja Chaudhari, and J. K. Badjatya. “Current Regulatory Requirements for Registration of Nutraceuticals in ASEAN”. International Journal of Drug Regulatory Affairs, Vol. 9, no. 4, Dec. 2021, pp. 37-45, doi:10.22270/ijdra.v9i4.501.

Most read articles by the same author(s)

1 2 > >>